Zobrazeno 1 - 10
of 397
pro vyhledávání: '"Stolovitzky G."'
Autor:
Stolovitzky, G. A., Kundaje, A., Held, G. A., Duggar, K. H., Haudenschild, C. D., Zhou, D., Vasicek, T. J., Smith, K. D., Aderem, A., Roach, J. C., Cantor, Charles R.
Publikováno v:
Proceedings of the National Academy of Sciences of the United States of America, 2005 Feb 01. 102(5), 1402-1407.
Externí odkaz:
https://www.jstor.org/stable/3374443
Publikováno v:
Proceedings of the National Academy of Sciences of the United States of America, 2002 Oct . 99(22), 14031-14036.
Externí odkaz:
https://www.jstor.org/stable/3073533
Autor:
Golob, JL, Oskotsky, TT, Tang, AS, Roldan, A, Chung, V, Ha, CWY, Wong, RJ, Flynn, KJ, Parraga-Leo, A, Wibrand, C, Minot, SS, Andreoletti, G, Kosti, I, Bletz, J, Nelson, A, Gao, J, Wei, Z, Chen, G, Tang, Z-Z, Novielli, P, Romano, D, Pantaleo, E, Amoroso, N, Monaco, A, Vacca, M, De Angelis, M, Bellotti, R, Tangaro, S, Kuntzleman, A, Bigcraft, I, Techtmann, S, Bae, D, Kim, E, Jeon, J, Joe, S, Preterm Birth DREAM Community, Theis, KR, Ng, S, Lee Li, YS, Diaz-Gimeno, P, Bennett, PR, MacIntyre, DA, Stolovitzky, G, Lynch, SV, Albrecht, J, Gomez-Lopez, N, Romero, R, Stevenson, DK, Aghaeepour, N, Tarca, AL, Costello, JC, Sirota, M
Publikováno v:
medRxiv
Globally, every year about 11% of infants are born preterm, defined as a birth prior to 37 weeks of gestation, with significant and lingering health consequences. Multiple studies have related the vaginal microbiome to preterm birth. We present a cro
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::85e402f3fbc397c0bf09a1acfb96ba88
https://doi.org/10.1101/2023.03.07.23286920
https://doi.org/10.1101/2023.03.07.23286920
Akademický článek
Tento výsledek nelze pro nepřihlášené uživatele zobrazit.
K zobrazení výsledku je třeba se přihlásit.
K zobrazení výsledku je třeba se přihlásit.
Akademický článek
Tento výsledek nelze pro nepřihlášené uživatele zobrazit.
K zobrazení výsledku je třeba se přihlásit.
K zobrazení výsledku je třeba se přihlásit.
Autor:
Menden M, Wang D, Mason M, Szalai B, Bulusu K, Guan Y, Yu T, Kang J, Jeon M, Wolfinger R, Nguyen T, Zaslavskiy M, Jang I, Ghazoui Z, Ahsen M, Vogel R, Neto E, Norman T, Tang E, Garnett M, Di Veroli G, Fawell S, Stolovitzky G, Guinney J, Dry J, Saez-Rodriguez J, Abante J, Abecassis B, Aben N, Aghamirzaie D, Aittokallio T, Akhtari F, Al-lazikani B, Alam T, Allam A, Allen C, de Almeida M, Altarawy D, Alves V, Amadoz A, Anchang B, Antolin A, Ash J, Aznar V, Ba-alawi W, Bagheri M, Bajic V, Ball G, Ballester P, Baptista D, Bare C, Bateson M, Bender A, Bertrand D, Wijayawardena B, Boroevich K, Bosdriesz E, Bougouffa S, Bounova G, Brouwer T, Bryant B, Calaza M, Calderone A, Calza S, Capuzzi S, Carbonell-Caballero J, Carlin D, Carter H, Castagnoli L, Celebi R, Cesareni G, Chang H, Chen G, Chen H, Cheng L, Chernomoretz A, Chicco D, Cho K, Cho S, Choi D, Choi J, Choi K, Choi M, De Cock M, Coker E, Cortes-Ciriano I, Cserzo M, Cubuk C, Curtis C, Van Daele D, Dang C, Dijkstra T, Dopazo J, Draghici S, Drosou A, Dumontier M, Ehrhart F, Eid F, ElHefnawi M, Elmarakeby H, van Engelen B, Engin H, de Esch I, Evelo C, Falcao A, Farag S, Fernandez-Lozano C, Fisch K, Flobak A, Fornari C, Foroushani A, Fotso D, Fourches D, Friend S, Frigessi A, Gao F, Gao X, Gerold J, Gestraud P, Ghosh S, Gillberg J, Godoy-Lorite A, Godynyuk L, Godzik A, Goldenberg A, Gomez-Cabrero D, Gonen M, de Graaf C, Gray H, Grechkin M, Guimera R, Guney E, Haibe-Kains B, Han Y, Hase T, He D, He L, Heath L, Hellton K, Helmer-Citterich M, Hidalgo M, Hidru D, Hill S, Hochreiter S, Hong S, Hovig E, Hsueh Y, Hu Z, Huang J, Huang R, Hunyady L, Hwang J, Hwang T, Hwang W, Hwang Y, Isayev O, Walk O, Jack J, Jahandideh S, Ji J, Jo Y, Kamola P, Kanev G, Karacosta L, Karimi M, Kaski S, Kazanov M, Khamis A, Khan S, Kiani N, Kim A, Kim J, Kim K, Kim S, Kim Y, Kirk P, Kitano H, Klambauer G, Knowles D, Ko M, Kohn-Luque A, Kooistra A, Kuenemann M, Kuiper M, Kurz C, Kwon M, van Laarhoven T, Laegreid A, Lederer S, Lee H, Lee J, Lee Y, Leppaho E, Lewis R, Li J, Li L, Liley J, Lim W, Lin C, Liu Y, Lopez Y, Low J, Lysenko A, Machado D, Madhukar N, De Maeyer D, Malpartida A, Mamitsuka H, Marabita F, Marchal K, Marttinen P, Mason D, Mazaheri A, Mehmood A, Mehreen A, Michaut M, Miller R, Mitsopoulos C, Modos D, Van Moerbeke M, Moo K, Motsinger-Reif A, Movva R, Muraru S, Muratov E, Mushthofa M, Nagarajan N, Nakken S, Nath A, Neuvial P, Newton R, Ning Z, De Niz C, Oliva B, Olsen C, Palmeri A, Panesar B, Papadopoulos S, Park J, Park S, Pawitan Y, Peluso D, Pendyala S, Peng J, Perfetto L, Pirro S, Plevritis S, Politi R, Poon H, Porta E, Prellner I, Preuer K, Pujana M, Ramnarine R, Reid J, Reyal F, Richardson S, Ricketts C, Rieswijk L, Rocha M, Rodriguez-Gonzalvez C, Roell K, Rotroff D, de Ruiter J, Rukawa P, Sadacca B, Safikhani Z, Safitri F, Sales-Pardo M, Sauer S, Schlichting M, Seoane J, Serra J, Shang M, Sharma A, Sharma H, Shen Y, Shiga M, Shin M, Shkedy Z, Shopsowitz K, Sinai S, Skola D, Smirnov P, Soerensen I, Soerensen P, Song J, Song S, Soufan O, Spitzmueller A, Steipe B, Suphavilai C, Tamayo S, Tamborero D, Tang J, Tanoli Z, Tarres-Deulofeu M, Tegner J, Thommesen L, Tonekaboni S, Tran H, De Troyer E, Truong A, Tsunoda T, Turu G, Tzeng G, Verbeke L, Videla S, Vis D, Voronkov A, Votis K, Wang A, Wang H, Wang P, Wang S, Wang W, Wang X, Wennerberg K, Wernisch L, Wessels L, van Westen G, Westerman B, White S, Willighagen E, Wurdinger T, Xie L, Xie S, Xu H, Yadav B, Yau C, Yeerna H, Yin J, Yu M, Yun S, Zakharov A, Zamichos A, Zanin M, Zeng L, Zenil H, Zhang F, Zhang P, Zhang W, Zhao H, Zhao L, Zheng W, Zoufir A, Zucknick M, AstraZeneca-Sanger Drug Combinatio
Publikováno v:
Nature Communications, Vol 10, Iss 1, Pp 1-17 (2019)
Nature Communications
Nature Communications, 10, 2674
r-IGTP. Repositorio Institucional de Producción Científica del Instituto de Investigación Germans Trias i Pujol
instname
Nature Communications, 10, pp. 1-17
Nature Communications 10, 2674 (2019). doi:10.1038/s41467-019-09799-2
Dipòsit Digital de la UB
Universidad de Barcelona
Nature communications, 10 (1
AstraZeneca-Sanger Drug Combination DREAM Consortium 2019, ' Community assessment to advance computational prediction of cancer drug combinations in a pharmacogenomic screen ', Nature Communications, vol. 10, no. 1, 2674 . https://doi.org/10.1038/s41467-019-09799-2
Nature Communications, 10:2674. Nature Publishing Group
NATURE COMMUNICATIONS
Nature Communications, 10, 1-17
Nature communications, vol 10, iss 1
Menden, M P, Wang, D, Mason, M J, Szalai, B, Bulusu, K C, Guan, Y, Yu, T, Kang, J, Jeon, M, Wolfinger, R, Nguyen, T, Zaslavskiy, M, AstraZeneca-Sanger Drug Combination DREAM Consortium, Jang, I S, Ghazoui, Z, Ahsen, M E, Vogel, R, Neto, E C, Norman, T, Tang, E K Y, Garnett, M J, Veroli, G Y D, Fawell, S, Stolovitzky, G, Guinney, J, Dry, J R & Saez-Rodriguez, J 2019, ' Community assessment to advance computational prediction of cancer drug combinations in a pharmacogenomic screen ', Nature Communications, vol. 10, no. 1, 2674 . https://doi.org/10.1038/s41467-019-09799-2
CONICET Digital (CONICET)
Consejo Nacional de Investigaciones Científicas y Técnicas
instacron:CONICET
r-FISABIO. Repositorio Institucional de Producción Científica
Repositório Científico de Acesso Aberto de Portugal
Repositório Científico de Acesso Aberto de Portugal (RCAAP)
instacron:RCAAP
Nature Communications, 10(1):2674. Nature Publishing Group
Recercat. Dipósit de la Recerca de Catalunya
Nature Communications
Nature Communications, 10, 2674
r-IGTP. Repositorio Institucional de Producción Científica del Instituto de Investigación Germans Trias i Pujol
instname
Nature Communications, 10, pp. 1-17
Nature Communications 10, 2674 (2019). doi:10.1038/s41467-019-09799-2
Dipòsit Digital de la UB
Universidad de Barcelona
Nature communications, 10 (1
AstraZeneca-Sanger Drug Combination DREAM Consortium 2019, ' Community assessment to advance computational prediction of cancer drug combinations in a pharmacogenomic screen ', Nature Communications, vol. 10, no. 1, 2674 . https://doi.org/10.1038/s41467-019-09799-2
Nature Communications, 10:2674. Nature Publishing Group
NATURE COMMUNICATIONS
Nature Communications, 10, 1-17
Nature communications, vol 10, iss 1
Menden, M P, Wang, D, Mason, M J, Szalai, B, Bulusu, K C, Guan, Y, Yu, T, Kang, J, Jeon, M, Wolfinger, R, Nguyen, T, Zaslavskiy, M, AstraZeneca-Sanger Drug Combination DREAM Consortium, Jang, I S, Ghazoui, Z, Ahsen, M E, Vogel, R, Neto, E C, Norman, T, Tang, E K Y, Garnett, M J, Veroli, G Y D, Fawell, S, Stolovitzky, G, Guinney, J, Dry, J R & Saez-Rodriguez, J 2019, ' Community assessment to advance computational prediction of cancer drug combinations in a pharmacogenomic screen ', Nature Communications, vol. 10, no. 1, 2674 . https://doi.org/10.1038/s41467-019-09799-2
CONICET Digital (CONICET)
Consejo Nacional de Investigaciones Científicas y Técnicas
instacron:CONICET
r-FISABIO. Repositorio Institucional de Producción Científica
Repositório Científico de Acesso Aberto de Portugal
Repositório Científico de Acesso Aberto de Portugal (RCAAP)
instacron:RCAAP
Nature Communications, 10(1):2674. Nature Publishing Group
Recercat. Dipósit de la Recerca de Catalunya
PubMed: 31209238
The effectiveness of most cancer targeted therapies is short-lived. Tumors often develop resistance that might be overcome with drug combinations. However, the number of possible combinations is vast, necessitating data-driven a
The effectiveness of most cancer targeted therapies is short-lived. Tumors often develop resistance that might be overcome with drug combinations. However, the number of possible combinations is vast, necessitating data-driven a
Akademický článek
Tento výsledek nelze pro nepřihlášené uživatele zobrazit.
K zobrazení výsledku je třeba se přihlásit.
K zobrazení výsledku je třeba se přihlásit.
Autor:
Cichońska, A., Ravikumar, B., Allaway, R., Wan, F., Park, S., Isayev, O., Li, S., Mason, M., Lamb, A., Tanoli, Z., Jeon, M., Kim, S., Popova, M., Capuzzi, S., Zeng, J., Dang, K., Koytiger, G., Kang, J., Wells, C., Willson, T., Lienhard, M., Prasse, P., Bachmann, I., Ganzlin, J., Barel, G., Herwig, R., Oprea, T., Schlessinger, A., Drewry, D., Stolovitzky, G., Wennerberg, K., Guinney, J., Aittokallio, T.
Publikováno v:
Nature Communications
Despite decades of intensive search for compounds that modulate the activity of particular protein targets, a large proportion of the human kinome remains as yet undrugged. Effective approaches are therefore required to map the massive space of unexp
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=od______1874::e1007e5831d53fbec840688212987446
https://hdl.handle.net/21.11116/0000-0008-C1E2-E21.11116/0000-0008-C1E4-C
https://hdl.handle.net/21.11116/0000-0008-C1E2-E21.11116/0000-0008-C1E4-C
Autor:
Kueffner R., Zach N., Bronfeld M., Norel R., Atassi N., Balagurusamy V., Di Camillo B., Chio A., Cudkowicz M., Dillenberger D., Garcia-Garcia J., Hardiman O., Hoff B., Knight J., Leitner M. L., Li G., Mangravite L., Norman T., Wang L., Xiao J., Fang W. -C., Peng J., Yang C., Chang H. -J., Stolovitzky G., Alkallas R., Anghel C., Avril J., Bacardit J., Balser B., Balser J., Bar-Sinai Y., Ben-David N., Ben-Zion E., Bliss R., Cai J., Chernyshev A., Chiang J. -H., Chicco D., Corriveau B. A. N., Dai J., Deshpande Y., Desplats E., Durgin J. S., Espiritu S. M. G., Fan F., Fevrier P., Fridley B. L., Godzik A., Golinska A., Gordon J., Graw S., Guo Y., Herpelinck T., Hopkins J., Huang B., Jacobsen J., Jahandideh S., Jeon J., Ji W., Jung K., Karanevich A., Koestler D. C., Kozak M., Kurz C., Lalansingh C., Larrieu T., Lazzarini N., Lerner B., Lesinski W., Liang X., Lin X., Lowe J., Mackey L., Meier R., Min W., Mnich K., Nahmias V., Noel-Macdonnell J., O'donnell A., Paadre S., Park J., Polewko-Klim A., Raghavan R., Rudnicki W., Saghapour E., Salomond J. -B., Sankaran K., Sendorek D., Sharan V., Shiah Y. -J., Sirois J. -K., Sumanaweera D. N., Usset J., Vang Y. S., Vens C., Wadden D., Wang D., Wong W. C., Xie X., Xu Z., Yang H. -T., Yu X., Zhang H., Zhang L., Zhang S., Zhu S.
Publikováno v:
Scientific Reports
Scientific reports, vol 9, iss 1
Scientific Reports, Vol 9, Iss 1, Pp 1-14 (2019)
Scientific reports, vol 9, iss 1
Scientific Reports, Vol 9, Iss 1, Pp 1-14 (2019)
Amyotrophic lateral sclerosis (ALS) is a fatal neurodegenerative disease where substantial heterogeneity in clinical presentation urgently requires a better stratification of patients for the development of drug trials and clinical care. In this stud
Akademický článek
Tento výsledek nelze pro nepřihlášené uživatele zobrazit.
K zobrazení výsledku je třeba se přihlásit.
K zobrazení výsledku je třeba se přihlásit.